NO864896D0 - Alfa-hydroksytioeter. - Google Patents

Alfa-hydroksytioeter.

Info

Publication number
NO864896D0
NO864896D0 NO864896A NO864896A NO864896D0 NO 864896 D0 NO864896 D0 NO 864896D0 NO 864896 A NO864896 A NO 864896A NO 864896 A NO864896 A NO 864896A NO 864896 D0 NO864896 D0 NO 864896D0
Authority
NO
Norway
Prior art keywords
single bond
group
optionally
phenylene
ethylene
Prior art date
Application number
NO864896A
Other languages
English (en)
Other versions
NO864896L (no
Inventor
Andreas Beck
Werner Breitenstein
Andreas Von Sprecher
Robert W Lang
Konrad Oertle
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO864896D0 publication Critical patent/NO864896D0/no
Publication of NO864896L publication Critical patent/NO864896L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Saccharide Compounds (AREA)
NO864896A 1985-12-06 1986-12-05 Alfa-hydroksytioeter. NO864896L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH522885 1985-12-06

Publications (2)

Publication Number Publication Date
NO864896D0 true NO864896D0 (no) 1986-12-05
NO864896L NO864896L (no) 1987-06-09

Family

ID=4290092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864896A NO864896L (no) 1985-12-06 1986-12-05 Alfa-hydroksytioeter.

Country Status (17)

Country Link
US (1) US4808572A (no)
EP (1) EP0225602B1 (no)
JP (1) JPS62138465A (no)
AT (1) ATE68177T1 (no)
AU (1) AU6613886A (no)
CA (1) CA1303294C (no)
DD (1) DD260494A5 (no)
DE (1) DE3681890D1 (no)
DK (1) DK586186A (no)
ES (1) ES2040205T3 (no)
FI (1) FI864901A (no)
GR (1) GR3003066T3 (no)
HU (1) HU196173B (no)
IL (1) IL80866A0 (no)
NO (1) NO864896L (no)
PT (1) PT83868B (no)
ZA (1) ZA869213B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149717A (en) * 1988-03-29 1992-09-22 Ciba-Geigy Corporation Alkanophenones useful for treating allergies
FR2648814B1 (fr) * 1989-06-26 1991-10-18 Lafon Labor L'alpha (tert-butyl-aminomethyl-3,4-dichlorobenzyl)thioacetamide, son procede de preparation et son application en therapeutique
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
DE59410387D1 (de) * 1993-01-29 2004-10-21 Ticona Gmbh Faserverstärktes Cycloolefincopolymer-Material, Verfahren zu seiner Herstellung und Formkörper aus dem Material
EP1689698A4 (en) * 2003-11-13 2007-09-05 Univ Sydney BISCATION COMPOUNDS AND THEIR APPLICATION
WO2007022718A1 (en) * 2005-08-25 2007-03-01 Chunde Liu Alkyl aryl alkyl alcohols, their derivations and preparation process thereof
JP2014503478A (ja) 2010-10-28 2014-02-13 マピ ファーマ リミテッド フィンゴリモドの調製のための中間の化合物およびプロセス
CN102850319A (zh) * 2011-06-27 2013-01-02 中国药科大学 一种制备{5-[2-(4-正辛基苯基)乙基]-2,2-二甲基-1,3-二氧六环-5-基}氨基甲酸叔丁酯的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3262587D1 (en) * 1981-03-03 1985-04-25 Lilly Industries Ltd Leukotriene analogues, their preparation and use in pharmaceutical compositions
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
US4461775A (en) * 1982-08-02 1984-07-24 Mcneilab, Inc. Hydroxythioether fatty acid derivatives
US4552893A (en) * 1983-03-07 1985-11-12 Smithkline Beckman Corporation Leukotriene antagonists
US4533747A (en) * 1983-03-07 1985-08-06 Smithkline Beckman Corporation Leukotriene antagonists intermediates
DK130984A (da) * 1983-03-07 1984-09-08 Smithkline Beckman Corp Leukotrien-antagonister
EP0123543B1 (en) * 1983-04-21 1988-02-03 Merck Frosst Canada Inc. Leukotriene antagonists, their production and use and compositions containing them
IL75620A (en) * 1984-06-28 1989-05-15 Ciba Geigy Aliphatic thioethers of alkanoic acid derivatives,their manufacture and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0225602B1 (de) 1991-10-09
FI864901A (fi) 1987-06-07
NO864896L (no) 1987-06-09
IL80866A0 (en) 1987-03-31
DD260494A5 (de) 1988-09-28
DE3681890D1 (en) 1991-11-14
HU196173B (en) 1988-10-28
GR3003066T3 (en) 1993-02-17
DK586186A (da) 1987-06-07
ES2040205T3 (es) 1993-10-16
ATE68177T1 (de) 1991-10-15
HUT43560A (en) 1987-11-30
EP0225602A2 (de) 1987-06-16
US4808572A (en) 1989-02-28
PT83868B (pt) 1989-07-31
ZA869213B (en) 1987-07-29
CA1303294C (en) 1992-06-09
AU6613886A (en) 1987-06-11
JPS62138465A (ja) 1987-06-22
EP0225602A3 (en) 1989-06-14
PT83868A (en) 1987-01-01
FI864901A0 (fi) 1986-12-01
DK586186D0 (da) 1986-12-05

Similar Documents

Publication Publication Date Title
DE3678545D1 (en) Aromatische thioether.
SE8302130L (sv) Farmakologiskt aktiva bifosfonater, forfarande for deras framstellning och farmaceutiska kompositioner innehallande desamma
GR850126B (no)
ES2004256A6 (es) Una composicion antioxidante a base de compuestos hidroxiarilicos y aminoarilicos.
FI864901A0 (fi) --hydroxitioetrar.
ES8405796A1 (es) Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables.
RU94002329A (ru) Модифицированные олигодезоксирибонуклеотиды, композиция, способ лечения и промежуточные соединения
ES8606260A1 (es) Procedimiento para la obtencion de tioeteres alifaticos
FI830397A0 (fi) Foerfarande foer framstaellning av imidazolidinderivat
DE69022442D1 (de) Aminoalkoxyphenyl-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen.
ZA833875B (en) Novel indolizine derivatives and process for preparing the same
GB2001066A (en) Preparation of benzylidene derivatives
FI873365A (fi) Foerfarande foer framstaellning av nya fosfo-foereningar.
KR870005984A (ko) α-하이드록시 티오에테르 및 이의 제조방법